Other

Banyu Pharmaceutical Co. Ltd

Yamaguchi University

Shibuya Corporation

Ajinomoto Co., Ltd.

Naoki Yamamoto

Kenji Yoneda

Shuji Terai

Isao Sakaida

Masazumi Yoshihara

Taro Takami

Masakazu Unten

Koichi Fujisawa

Nobuyuki Kobayashi

Yoshiaki Hamamoto

A method for evaluating the activity level of mesenchymal stem cells, and a method for culturing mesenchymal stem cells using the evaluation method in the field of culturing mesenchymal stem cells for regenerative medicine, and further, a method for producing a therapeutic agent for liver dysfunction and a therapeutic agent for liver dysfunction. This method for evaluating mesenchymal stem cell activity has an assay step for assaying the amount of adenylate kinase 4 (AK4) in the mesenchymal stem cells; and a determination step for determining the activity level of the mesenchymal stem cells from the assayed amount of adenylate kinase 4.

Method for evaluating mesenchymal stem cell activity, method for culturing mesenchymal stem cells, method for producing therapeutic agent for liver dysfunction, and therapeutic agent for liver dysfunction

An anti-AIDS viral agent and anticancer agent comprising as an effective ingredient in the extract containing polysaccharides from nutshells of nuts belonging to the genus Juglans or the genus Carya of angiosperm Juglandaceae with an alkali aqueous solution is disclosed. The extract has anti-HIV effect at the concentration ranging from 64 to 512 .mu.g/ml and exhibits an increased life span in animal.

Methods of disease inhibition using acid polysaccharides extracted from

The invention is a cloned T cell prepared by infecting a human T cell, H9, with HTLV-III B, which cloned human T cell is antigenic for HTLV-III B, does not have a syncytium-forming activity, and does not produce infectious HTLV-III B virions.

Antigenic noninfectious HIV-producing cloned T cell

Growing community of inventors

Ube, Japan

Naoki Yamamoto